![CytoMed Therapeutics Ltd](/common/images/company/N_GDTC.png)
CytoMed Therapeutics Ltd (GDTC)
NASDAQ
Quarter End | ||||
---|---|---|---|---|
SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
Total Revenue | ||||
Operating Income | ||||
Pre Tax Income | ||||
Net Income | ||||
Preferred Dividends | ||||
Basic Earnings Per Share (EPS) | ||||
EBIT | ||||
EBITDA |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
SGD ($) | SGD ($) | SGD ($) | SGD ($) | |
Total Revenue | 127.46M | 151.24M | 484k | 518k |
Operating Income | -1.26B | -1.94B | -1.49M | -3.87M |
Pre Tax Income | -1.94B | -2.05B | -3.13M | -4.13M |
Net Income | -1.94B | -2.05B | -3.13M | -4.13M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.318 | -0.274 | 0 | 0 |
EBIT | -1.83B | -1.93B | -2.58M | -4.2M |
EBITDA | -963.72M | -1.61B | -1.1M | -3.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.